Ventricular Intramyocardial Dissecting Hematoma: What Is its True Clinical Evolution and the Best Treatment?

Sergio Moral1,2, Sandra Martinez-Ballart3, Esther Ballesteros4

  • 1Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona, Spain.

JACC. Case Reports
|January 11, 2024
PubMed

Insights

Intramyocardial dissecting hematoma, a rare cardiac rupture during acute coronary syndrome, lacks defined treatment guidelines. This case discusses the optimal management and outcome for this critical condition.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pathology

Background:

  • Intramyocardial dissecting hematoma (IDH) is a rare complication of acute coronary syndrome.
  • IDH represents a form of cardiac rupture with unclear optimal management strategies.
  • The clinical presentation and therapeutic approaches for IDH require further elucidation.

Purpose of the Study:

  • To present a clinical case of intramyocardial dissecting hematoma.
  • To discuss the optimal treatment strategy for IDH in a specific clinical context.
  • To analyze the final outcome of the presented IDH case.

Main Methods:

  • Case report presentation.
  • Review of clinical data and diagnostic findings.
  • Discussion of therapeutic interventions and patient outcomes.

Main Results:

  • A case of intramyocardial dissecting hematoma associated with acute coronary syndrome was successfully managed.
  • The chosen treatment approach for IDH led to a favorable patient outcome.
  • The case highlights the importance of individualized management for IDH.

Conclusions:

  • Optimal treatment for intramyocardial dissecting hematoma depends on the specific clinical scenario.
  • Prompt diagnosis and tailored therapeutic strategies are crucial for managing IDH.
  • Further case studies are needed to refine treatment guidelines for IDH.